25 July 2013 - Deborah Wilkes
Archived
Generics firm Actavis is considering a range of strategic alternatives, including divestment, for its operations in a number of countries in Western Europe.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.